A Medical Device Daily

Midmark (Versailles, Ohio) reported this week that it will close its Orchard Park, Ohio, facility, shifting its dental and veterinary divisions to its manufacturing facility in Versailles. The closure will affect 80 employees

The relocation of all production and support for its air, vacuum and anesthesia product lines from Orchard Park will be completed in about 90 days.

Blaming economic conditions, the company said in a statement that the Orchard Park site was "substantially" under capacity and was affecting Midmark's cost position and earnings.

"The current economic condition has negatively impacted Midmark, as it has many businesses," said president/CEO Anne Eiting Klamar. "This was not an easy decision to make, but after careful consideration, we believe that it is the best thing to do for the long-term security of Midmark and its teammates.

Last November, Midmark reported the sale of its dental nitrous oxide product line to Parker Hannifin (Cleveland), which relocated the operation from Orchard Park to Hatfield, Pennsylvania. Terms of the agreement for the product line, which had about $7 million in sales, were not disclosed.

A company official said some employees may relocate to the Versailles facility, and the company will provide outplacement resources to all staffers affected.

At the time, the company said the local site would continue to manufacture a growing range of dental and veterinary products.

According to the Dayton Business Journal, Midmark has more than $200 million in annual revenue and has seen double-digit growth in recent years. The company, with 1,100 employees nationwide, focused on healthcare manufacturing of chairs, furniture and equipment and expanded in recent years into the dental and veterinary lines.